Ali Asif
SEC insider (Form 3/4/5 filer). CIK 0001921163. Chief Financial Officer at Protagonist Therapeutics, Inc (PTGX). 27 reported Form 4/5 transactions since Sep 2024; latest on Sep 30, 2026. Located in NEWARK, CA.
Companies Ali Asif has filed insider reports for
- Protagonist Therapeutics, Inc (PTGX): Officer, Chief Financial Officer
Ali Asif
CIK: 0001921163
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Protagonist Therapeutics, Inc
Discretionary Trading P&L
Holdings
Transaction History (27 total)
- Sep 30, 2026PTGX
Protagonist Therapeutics, Inc
ExerciseDirect15.7K shares at avg. $19.19$300K - Sep 30, 2026PTGX
Protagonist Therapeutics, Inc
ExerciseDirect28.4K shares at avg. $23.42$666K - Sep 30, 2026PTGX
Protagonist Therapeutics, Inc
ExerciseDirect9.2K shares at avg. $38.98$360K - Sep 30, 2026PTGX
Protagonist Therapeutics, Inc
ExerciseDirect5.3K shares at avg. $12.17$65K - Sep 30, 2026PTGX
Protagonist Therapeutics, Inc
SaleDirect12.6K shares at avg. $141.77$1.8M - Sep 30, 2026PTGX
Protagonist Therapeutics, Inc
SaleDirect46K shares at avg. $141.78$6.5M - Apr 20, 2026PTGX
Protagonist Therapeutics, Inc
SaleDirect1.8K shares at avg. $105.47$185K - Mar 26, 2026PTGX
Protagonist Therapeutics, Inc
ExerciseDirect19.5K shares at avg. $19.19$374K - Mar 26, 2026PTGX
Protagonist Therapeutics, Inc
ExerciseDirect5.3K shares at avg. $12.17$64K - Mar 26, 2026PTGX
Protagonist Therapeutics, Inc
SaleDirect24.8K shares at avg. $104.24$2.6M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 | PTGX Protagonist Therapeutics, Inc | Exercise | 15,650 | $19.19 | $300,324 | Direct |
| Sep 30, 2026 | PTGX Protagonist Therapeutics, Inc | Exercise | 28,438 | $23.42 | $666,018 | Direct |
| Sep 30, 2026 | PTGX Protagonist Therapeutics, Inc | Exercise | 9,229 | $38.98 | $359,746 | Direct |
| Sep 30, 2026 | PTGX Protagonist Therapeutics, Inc | Exercise | 5,312 | $12.17 | $64,647 | Direct |
| Sep 30, 2026 | PTGX Protagonist Therapeutics, Inc | Sale | 12,595 | $141.77 | $1,785,593 | Direct |
| Sep 30, 2026 | PTGX Protagonist Therapeutics, Inc | Sale | 46,034 | $141.78 | $6,526,701 | Direct |
| Apr 20, 2026 | PTGX Protagonist Therapeutics, Inc | Sale | 1,750 | $105.47 | $184,573 | Direct |
| Mar 26, 2026 | PTGX Protagonist Therapeutics, Inc | Exercise | 19,500 | $19.19 | $374,205 | Direct |
| Mar 26, 2026 | PTGX Protagonist Therapeutics, Inc | Exercise | 5,265 | $12.17 | $64,075 | Direct |
| Mar 26, 2026 | PTGX Protagonist Therapeutics, Inc | Sale | 24,765 | $104.24 | $2,581,504 | Direct |
1-10 of 27 transactions